Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer.

Saved in:
Bibliographic Details
Title: Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer.
Authors: Chen WY; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, 11031, Taiwan.; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan., Huang KH; Department of Surgery, Division of Urology, Chi-Mei Medical Center, Tainan, 710, Taiwan., Kajla G; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Wen YC; Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, 11031, Taiwan.; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, 11031, Taiwan., Liu MK; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Fan YC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Dung PVT; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Yeh HL; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Chen WH; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Jiang KC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Li HR; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan., Chen CS; School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan., Huang J; Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, 02215-5450, USA., Liu YN; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan. liuy@tmu.edu.tw.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan. liuy@tmu.edu.tw.; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei Medical University, Taipei, 11031, Taiwan. liuy@tmu.edu.tw.; Taipei Medical University, 301, Yuantong Road, Zhonghe District, New Taipei City, 234, Taiwan. liuy@tmu.edu.tw.
Source: Cell communication and signaling : CCS [Cell Commun Signal] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42252434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+WY%22">Chen WY</searchLink>; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, 11031, Taiwan.; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+KH%22">Huang KH</searchLink>; Department of Surgery, Division of Urology, Chi-Mei Medical Center, Tainan, 710, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kajla+G%22">Kajla G</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wen+YC%22">Wen YC</searchLink>; Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, 11031, Taiwan.; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liu+MK%22">Liu MK</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Fan+YC%22">Fan YC</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Dung+PVT%22">Dung PVT</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeh+HL%22">Yeh HL</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+WH%22">Chen WH</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Jiang+KC%22">Jiang KC</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Li+HR%22">Li HR</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CS%22">Chen CS</searchLink>; School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+J%22">Huang J</searchLink>; Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, 02215-5450, USA.<br /><searchLink fieldCode="AU" term="%22Liu+YN%22">Liu YN</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan. liuy@tmu.edu.tw.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City, 235, Taiwan. liuy@tmu.edu.tw.; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei Medical University, Taipei, 11031, Taiwan. liuy@tmu.edu.tw.; Taipei Medical University, 301, Yuantong Road, Zhonghe District, New Taipei City, 234, Taiwan. liuy@tmu.edu.tw.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101170464%22">Cell communication and signaling : CCS</searchLink> [Cell Commun Signal] 2026 Jun 08. <i>Date of Electronic Publication: </i>2026 Jun 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170464 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-811X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221478811X%22">1478811X </searchLink><i>NLM ISO Abbreviation: </i>Cell Commun Signal <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42252434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12964-026-02977-y
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen WY
      – PersonEntity:
          Name:
            NameFull: Huang KH
      – PersonEntity:
          Name:
            NameFull: Kajla G
      – PersonEntity:
          Name:
            NameFull: Wen YC
      – PersonEntity:
          Name:
            NameFull: Liu MK
      – PersonEntity:
          Name:
            NameFull: Fan YC
      – PersonEntity:
          Name:
            NameFull: Dung PVT
      – PersonEntity:
          Name:
            NameFull: Yeh HL
      – PersonEntity:
          Name:
            NameFull: Chen WH
      – PersonEntity:
          Name:
            NameFull: Jiang KC
      – PersonEntity:
          Name:
            NameFull: Li HR
      – PersonEntity:
          Name:
            NameFull: Chen CS
      – PersonEntity:
          Name:
            NameFull: Huang J
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: Liu YN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 06
              Text: 2026 Jun 08
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1478-811X
          Titles:
            – TitleFull: Cell communication and signaling : CCS
              Type: main
ResultId 1